Neil Berkley

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Neil Berkley

AbCellera Biologics Inc. reported in an 8-K filed July 19, 2022 that Neil Berkley was terminated as Chief Business Officer, effective June 29, 2022.

“the Company terminated Employee’s employment with the Company effective June 29, 2022 (the “Termination Date”)”

AbCellera Biologics Inc. Form 8-K, filed July 19, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Neil Berkley's recent executive appointments or departures and cite the source filings.”

Recorded current and former roles; source labels appear when available.

Recorded roles and call appearances connecting this person to public companies.

ABCL

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.